SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910443 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von V P Snijesh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore 560034, Karnataka, India. Hauptthemen laut MEDLINE: Hedgehog Proteins, Endometrial Neoplasms, Tumor Microenvironment, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah.
Abstract (Originalsprache)
Endometrial Cancer (EC) is one of the most common gynecological malignancies. Despite its prevalence, molecular pathways, such as the Sonic Hedgehog (SHH) pathway, have not been extensively studied in the context of EC. This study aims to explore the clinical implications of SHH expression in EC, potentially uncovering new insights into the disease’s pathogenesis and offering valuable insights for therapeutic strategies in EC. We utilized data from The Cancer Genome Atlas (TCGA) to divide the dataset into ‘High SHH’ and ‘Low SHH’ groups based on a gene signature score derived from SHH pathway-related genes. We explored the clinical and tumor characteristics of these groups, focusing on key cancer hallmarks, including stemness, proliferation, cytolytic activity, tumor micro-environment, and genomic instability. ‘High SHH’ tumors emerged as a distinct category with favorable clinical and molecular features. These tumors exhibited lower proliferation rates, reduced angiogenesis, and diminished genomic instability, indicating a controlled and less aggressive tumor growth pattern. Moreover, ‘High SHH’ tumors displayed lower stemness, highlighting a less invasive phenotype. The immune micro-environment in ‘High SHH’ tumors was enriched with immune cell types, such as macrophage M0, monocytes, B cells, CD8 T cells, CD4 T cells, follicular helper T cells, and natural killer cells. This immune enrichment, coupled with higher cytolytic activity, suggested an improved anti-tumor immune response. Our study sheds light on the clinical significance of Sonic signaling in EC. ‘High SHH’ tumors exhibit a unique molecular and clinical profile associated with favorable cancer hallmarks, lower grades, and better survival. These findings underscore the potential utility of SHH expression as a robust prognostic biomarker, offering valuable insights for tailored therapeutic strategies in EC. Understanding the SHH pathway’s role in EC contributes to our growing knowledge of this cancer and may pave the way for more effective treatment strategies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Medicine, St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore 560034, Karnataka, India.
- Tsinghua Berkeley Shenzhen Institute, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Electronics & Communication Engineering, Excel College of Technology, Namakkal 637303, Tamilnadu, India.
- Department of Psychiatry, National Institute of Mental Health And Neuro Sciences, Bangalore 560029, Karnataka, India.
- Department of Genetic Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Princess Al-Jawhara Al-Brahim Center of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID-Profile: V P Snijesh, Vipul Bhardwaj, Mahmoud Almutadares, Noor Ahmad Shaik
Förderung
- Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah
Zitieren
APA
Snijesh, V. P., Krishnamurthy, S., Bhardwaj, V., Punya, K. M., Niranjana Murthy, A. S., Almutadares, M., Habhab, W. T., Nasser, K. K., Banaganapalli, B., Shaik, N. A., & Albaqami, W. F. (2024). SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910443
Vancouver
Snijesh VP, Krishnamurthy S, Bhardwaj V, Punya KM, Niranjana Murthy AS, Almutadares M, et al. SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910443
BibTeX
@article{Snijesh2024,
author = {Snijesh, V P and Krishnamurthy, Shivakumar and Bhardwaj, Vipul and Punya, K M and Niranjana Murthy, Ashitha S and Almutadares, Mahmoud and Habhab, Wisam Tahir and Nasser, Khalidah Khalid and Banaganapalli, Babajan and Shaik, Noor Ahmad and Albaqami, Walaa F},
title = {SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910443}
}
EUVIMED